Run the national screening programmes end-to-end — and go further: offer earlier screening to the people most at risk, by their recorded family history. Detection that finds disease sooner in the people a fixed age-based programme would miss.
Live vs demonstrated:Live — real, API-backed platform logic (wired end-to-end today)Demonstrated — representative control surface with seeded data / illustrative UI mock-up
Three capabilities, one prevention surface
National call/recall stays exactly as the programmes require; the builder and the smart layer sit on top, sharing the same person record.
National Screening Management
Call/recall · failsafe · NHSDSS
Bowel, cervical, breast, diabetic-eye and AAA programmes — uptake, overdue counts, results inbox, failsafe register and submission, synchronised with the national services.
Where in commvita/screening-programmes · ◎ Demonstrated
Screening Builder
No-code, standard or risk-based
Create a new screening programme — age band, sex, interval, modality and target uptake — without waiting for a national scheme. Standard or risk-based.
Where in commvita/smart-screening · ● Live
Smart (hereditary) Screening
Earlier screening by family history
Target people with a recorded family history of a condition for earlier surveillance — bowel & breast cancer, familial hypercholesterolaemia, AAA and more — then invite the cohort in one step.
Demonstrated surface — national programmes, uptake vs target, overdue & last sync
Bowel Cancer (BCS)
68% uptake · target 75%
47 overdue · Below target
Breast Screening
71% uptake · target 75%
34 overdue · Below target
Diabetic Eye (DESP)
82% uptake · target 85%
28 overdue
+ New / Smart Screening →Failsafe register
Representative UI — national programme data synchronised (BCSS / NHAIS / Open Exeter); builder & smart layer reached from the header
commvita™
Connected care platform
Page 2 of 3
2Smart screening — earlier detection, safely
A fixed age-based programme screens everyone at the same age. Smart screening screens the people who need it sooner — those a relative's diagnosis has put at higher risk — from data the practice already holds.
1
Record the family-history flag
A clinician (or the patient, via the portal) records a family history of a condition — relation, risk level. A recorded fact, not a genomic result.
2
Pick the condition & the earlier-from age
Choose from the clinically-referenced catalogue (below); each carries an evidence-based earlier-screening age and pathway.
3
Preview the eligible cohort
The platform resolves exactly the people with that recorded family history in the earlier age band — count and list reconcile.
4
Invite via the Communications CRM
One click hands the cohort to the unified CRM cohort/broadcast — invitation templated, contact preferences honoured.
The information-governance line — deliberately drawn. Smart screening targets people from a recorded family-history flag (patient-reported or clinician-recorded). The lawful basis is preventive medicine / direct care — UK GDPR Art 6(1)(e)Art 9(2)(h). Genomic data is not used here. Genomic and pedigree-based targeting is a different, higher bar: it stays in the Genomics module behind explicit Article 9 consent and the genomics_access role (panel · pedigree · consent). Family history opens the door to earlier screening today, without touching genomic data.
Condition catalogue — earlier screening on a positive family history
Condition (family history of…)
Standard from
Earlier from
Pathway
Bowel cancer
60
● 40
Earlier colonoscopy surveillance
Breast cancer
50
● 40
Earlier / annual mammography or MRI (NICE CG164)
Familial hypercholesterolaemia
—
● 10
Cascade lipid testing (NICE CG71)
Abdominal aortic aneurysm
65
● 50
Earlier AAA ultrasound (first-degree relative)
Ovarian cancer
—
● 35
Gynae-oncology familial-risk referral
Type 2 diabetes · Glaucoma
40
● 25 / 35
Earlier HbA1c / IOP review (strong family history)
commvita / Smart Screeningcare coordinator
Live surface — family-history cohort preview → invite via CRM
Condition (family history of…)
Bowel cancer
Earlier from
40
To age
59
Preview eligible cohort
18
people with a recorded family history of bowel cancer, aged 40–59
Invite cohort via CRM →
Basis: recorded family history (non-genomic) · Art 6(1)(e) + 9(2)(h). Genomic targeting excluded.
Representative UI — eligible count and list reconcile; the invite hands the cohort to the Communications CRM
commvita™
Connected care platform
Page 3 of 3
3Build your own programme
Not every screen is national. Stand up a local programme — case-finding, a risk-based recall — in the same surface, with the same recall and CRM machinery behind it.
Standard programme
Age / sex / interval / modality
Name it, set the eligible age band and sex, the recall interval and target uptake, pick the modality (FIT, spirometry, bloods, ultrasound…). It joins the register immediately.
Risk-based programme
Bound to a family-history cohort
Flag a programme risk-based and bind it to a condition's family-history cohort — the eligible list is the people at hereditary risk, screened earlier, on a standing basis.
Where it lives in commvita today
Capability
Module
Route
Status
National call/recall (bowel/cervical/breast/DESP/AAA)
Screening Programmes
/screening-programmes
◎ Demonstrated
Create a programme (standard or risk-based)
Smart Screening
/smart-screening
● Live
Hereditary-risk targeting + cohort preview
Smart Screening
/smart-screening
● Live
Family-history register (non-genomic flag)
Smart Screening
/smart-screening
● Live
Invite the cohort (preferences honoured)
Communications CRM
/comms-crm
● Live
Genomic / pedigree targeting (Art.9 consent)
Genomics
/genomics
● Gated
Honest state. The smart-screening cohort logic, family-history register, SNOMED/FHIR export and CRM invite are API-backed and wired end-to-end; the national programme overview is a demonstrated surface (representative seeded data — not yet synchronised with BCSS/NHAIS/Open Exeter). Seeded demonstration flags populate the cohort preview out of the box. The clinical earlier-screening ages/pathways are referenced to national guidance (NICE CG164 breast familial risk, CG71 FH). Non-SaMD: the platform surfaces eligibility and records the invitation — the screening decision and any onward referral remain the clinician's.